New dry eye drop shows similar safety to standard artificial tears

NCT ID NCT06660290

Completed Symptom relief Sponsor: Alcon Research Source: ClinicalTrials.gov ↗

First seen Mar 27, 2026 · Last updated May 23, 2026 · Updated 8 times

Summary

This study tested a new eye drop (AR-15512) for dry eye disease in 55 adults. The goal was to see how many people had eye-related side effects compared to a standard artificial tear (REFRESH® Classic). Results help understand the safety of this new drop for future use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Advancing Vision Research, LLC

Smyrna, Tennessee, 37167, United States
Andover Eye Associates

Andover, Massachusetts, 01810, United States
Eye Research Foundation

Newport Beach, California, 92663, United States
Piedmont Eye Center

Lynchburg, Virginia, 24502, United States
Total Eye Care, PA

Memphis, Tennessee, 38119, United States
Vision Institute

Colorado Springs, Colorado, 80907, United States

Conditions

Explore the condition pages connected to this study.

DRY EYE DISEASE